Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Latest News · page 5
- Prescribers & Clinics
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country’s professional medical community continues to face.
- US & Canada
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- M&A Activity
Sanity Group Deepens Swiss Footprint With Astrasana Distribution Deal
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
- Pharmaceutical
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
- Patient Access
Ukraine Issues First Medical Cannabis Prescriptions, Two Years After Legalisation
First published on Cannabis Health On Thursday, 11 June, the first medical cannabis products were prescribed by neurologists at the Vinnytsia Regional Clinical Psychoneurological Hospital to Lyudmila Monastyrska, a patient with multiple sclerosis, and Yaroslav Yurchuk, a veteran who lost his leg a year ago while fighting in the Pokrovsk area.
- Press releases
Taima Growth Becomes Spain’s Fourth AEMPS-Licensed Medical Cannabis Cultivator
A Spanish startup has become one of only four companies authorised by Spain’s medicines regulator to cultivate medical cannabis, positioning itself to supply export markets in the UK and Germany from a pharmaceutical-grade indoor facility in the Ribera region of Burgos.
- US & Canada
Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use
The critical June 29 administrative hearing, set to determine whether the US will extend rescheduling efforts to recreational cannabis, is now set to be a fiercely contested event.
- International Regulation
Stop Consulting, Start Implementing: South Africa’s Cannabis Industry Demands Action as Businesses Suffer
South Africa’s long-suffering cannabis operators have demanded that the government make good on its extensive plans for a regulated framework, as frustration with its lack of meaningful action reaches a boiling point.
- International Regulation
Australian State to End Automatic Licence Loss for Medical Cannabis Drivers
Australia’s New South Wales has moved to end the automatic penalisation of medicinal cannabis patients caught driving with THC in their system, introducing a registration and threshold-based framework that leaves most of Australia’s one million cannabis patients still without equivalent protection.
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
